Introducing PIONEER: a project to harness big data in prostate cancer research

Muhammad Imran Omar; Monique J. Roobol; Maria J. Ribal; Thomas Abbott; Paul-Michael Agapow; Sonia Araujo; Alex Asiimwe; Charles Auffray; Irina Balaur; Katharina Bayer; Chiara Bernini; Anders Bjartell; Alberto Briganti; John-Edward Butler-Ransohoff; Riccardo Campi; Marinel Cavelaars; Bertrand De Meulder; Zsuzsanna Devecseri; Marc Dietrich Voss; Konstantinos Dimitropoulos; Susan Evans-Axelsson; Billy Franks; Louise Fullwood; Denis Horgan; Emma Jane Smith; Amit Kiran; Kati Kivinummi; Mark Lambrecht; Doron Lancet; Peter Lindgren; Sara MacLennan; Steven MacLennan; Maria Manuela Nogueira; Fredrik Moen; Maxim Moinat; Kishore Papineni; Christian Reich; Kristin Reiche; Stijn Rogiers; Claudio Sartini; Kees van Bochove; Femke van Diggelen; Mieke van Hemelrijck; Hein Van Poppel; Jihong Zong; James N'Dow; The PIONEER Consortium

doi:10.1038/s41585-020-0324-x

Introducing PIONEER: a project to harness big data in prostate cancer research

Muhammad Imran Omar^* (Corresponding Author), Monique J. Roobol, Maria J. Ribal, Thomas Abbott, Paul-Michael Agapow, Sonia Araujo, Alex Asiimwe, Charles Auffray, Irina Balaur, Katharina Bayer, Chiara Bernini, Anders Bjartell, Alberto Briganti, John-Edward Butler-Ransohoff, Riccardo Campi, Marinel Cavelaars, Bertrand De Meulder, Zsuzsanna Devecseri, Marc Dietrich Voss, Konstantinos DimitropoulosSusan Evans-Axelsson, Billy Franks, Louise Fullwood, Denis Horgan, Emma Jane Smith, Amit Kiran, Kati Kivinummi, Mark Lambrecht, Doron Lancet, Peter Lindgren, Sara MacLennan, Steven MacLennan, Maria Manuela Nogueira, Fredrik Moen, Maxim Moinat, Kishore Papineni, Christian Reich, Kristin Reiche, Stijn Rogiers, Claudio Sartini, Kees van Bochove, Femke van Diggelen, Mieke van Hemelrijck, Hein Van Poppel, Jihong Zong, James N'Dow, The PIONEER Consortium

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

40 Downloads (Pure)

Abstract

Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe. Launched by the Innovative Medicines Initiative 2 and part of the Big Data for Better Outcomes Programme (BD4BO), the overarching goal of PIONEER is to provide high-quality evidence on prostate cancer management by unlocking the potential of big data. The project has identified critical evidence gaps in prostate cancer care, via a detailed prioritization exercise including all key stakeholders. By standardizing and integrating existing high-quality and multidisciplinary data sources from patients with prostate cancer across different stages of the disease, the resulting big data will be assembled into a single innovative data platform for research. Based on a unique set of methodologies, PIONEER aims to advance the field of prostate cancer care with a particular focus on improving prostate-cancer-related outcomes, health system efficiency by streamlining patient management, and the quality of health and social care delivered to all men with prostate cancer and their families worldwide.

Original language	English
Pages (from-to)	351-362
Number of pages	12
Journal	Nature reviews. Urology
Volume	17
Early online date	27 May 2020
DOIs	https://doi.org/10.1038/s41585-020-0324-x https://doi.org/10.1038/s41585-020-0355-3
Publication status	Published - 25 Jun 2020

Bibliographical note

Author Correction: 25 June 2020
The originally published article contained errors in Figure 1 and did not reflect the current organization of the PIONEER consortium. The figure has been corrected in the HTML and PDF versions of the manuscript to reflect the correct organization of PIONEER.

Acknowledgements
PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Keywords

prostate
prostate cancer
SET
MEN
SURVEILLANCE
RISK
PATIENT-CENTERED OUTCOMES

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41585-020-0324-xLicence: Unspecified
10.1038/s41585-020-0355-3Licence: Unspecified

Omar_NRU_AAM_In_principleAccepted author manuscript, 1.15 MBLicence: Other

Cite this

Omar, M. I., Roobol, M. J., Ribal, M. J., Abbott, T., Agapow, P.-M., Araujo, S., Asiimwe, A., Auffray, C., Balaur, I., Bayer, K., Bernini, C., Bjartell, A., Briganti, A., Butler-Ransohoff, J.-E., Campi, R., Cavelaars, M., De Meulder, B., Devecseri, Z., Voss, M. D., ... The PIONEER Consortium (2020). Introducing PIONEER: a project to harness big data in prostate cancer research. Nature reviews. Urology, 17, 351-362. https://doi.org/10.1038/s41585-020-0324-x, https://doi.org/10.1038/s41585-020-0355-3

Omar, MI, Roobol, MJ, Ribal, MJ, Abbott, T, Agapow, P-M, Araujo, S, Asiimwe, A, Auffray, C, Balaur, I, Bayer, K, Bernini, C, Bjartell, A, Briganti, A, Butler-Ransohoff, J-E, Campi, R, Cavelaars, M, De Meulder, B, Devecseri, Z, Voss, MD, Dimitropoulos, K, Evans-Axelsson, S, Franks, B, Fullwood, L, Horgan, D, Smith, EJ, Kiran, A, Kivinummi, K, Lambrecht, M, Lancet, D, Lindgren, P, MacLennan, S , MacLennan, S, Nogueira, MM, Moen, F, Moinat, M, Papineni, K, Reich, C, Reiche, K, Rogiers, S, Sartini, C, van Bochove, K, van Diggelen, F, van Hemelrijck, M, Van Poppel, H, Zong, J, N'Dow, J & The PIONEER Consortium 2020, 'Introducing PIONEER: a project to harness big data in prostate cancer research', Nature reviews. Urology, vol. 17, pp. 351-362. https://doi.org/10.1038/s41585-020-0324-x, https://doi.org/10.1038/s41585-020-0355-3

@article{ff9e93c08cb24bdba68427035e005295,

title = "Introducing PIONEER: a project to harness big data in prostate cancer research",

abstract = "Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe. Launched by the Innovative Medicines Initiative 2 and part of the Big Data for Better Outcomes Programme (BD4BO), the overarching goal of PIONEER is to provide high-quality evidence on prostate cancer management by unlocking the potential of big data. The project has identified critical evidence gaps in prostate cancer care, via a detailed prioritization exercise including all key stakeholders. By standardizing and integrating existing high-quality and multidisciplinary data sources from patients with prostate cancer across different stages of the disease, the resulting big data will be assembled into a single innovative data platform for research. Based on a unique set of methodologies, PIONEER aims to advance the field of prostate cancer care with a particular focus on improving prostate-cancer-related outcomes, health system efficiency by streamlining patient management, and the quality of health and social care delivered to all men with prostate cancer and their families worldwide.",

keywords = "prostate, prostate cancer, SET, MEN, SURVEILLANCE, RISK, PATIENT-CENTERED OUTCOMES",

author = "Omar, {Muhammad Imran} and Roobol, {Monique J.} and Ribal, {Maria J.} and Thomas Abbott and Paul-Michael Agapow and Sonia Araujo and Alex Asiimwe and Charles Auffray and Irina Balaur and Katharina Bayer and Chiara Bernini and Anders Bjartell and Alberto Briganti and John-Edward Butler-Ransohoff and Riccardo Campi and Marinel Cavelaars and {De Meulder}, Bertrand and Zsuzsanna Devecseri and Voss, {Marc Dietrich} and Konstantinos Dimitropoulos and Susan Evans-Axelsson and Billy Franks and Louise Fullwood and Denis Horgan and Smith, {Emma Jane} and Amit Kiran and Kati Kivinummi and Mark Lambrecht and Doron Lancet and Peter Lindgren and Sara MacLennan and Steven MacLennan and Nogueira, {Maria Manuela} and Fredrik Moen and Maxim Moinat and Kishore Papineni and Christian Reich and Kristin Reiche and Stijn Rogiers and Claudio Sartini and {van Bochove}, Kees and {van Diggelen}, Femke and {van Hemelrijck}, Mieke and {Van Poppel}, Hein and Jihong Zong and James N'Dow and {The PIONEER Consortium}",

note = "Author Correction: 25 June 2020 The originally published article contained errors in Figure 1 and did not reflect the current organization of the PIONEER consortium. The figure has been corrected in the HTML and PDF versions of the manuscript to reflect the correct organization of PIONEER. Acknowledgements PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint undertaking receives support from the European Union{\textquoteright}s Horizon 2020 research and innovation programme and EFPIA.",

year = "2020",

month = jun,

day = "25",

doi = "10.1038/s41585-020-0324-x",

language = "English",

volume = "17",

pages = "351--362",

journal = "Nature reviews. Urology",

issn = "1759-4820",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Introducing PIONEER

T2 - a project to harness big data in prostate cancer research

AU - Omar, Muhammad Imran

AU - Roobol, Monique J.

AU - Ribal, Maria J.

AU - Abbott, Thomas

AU - Agapow, Paul-Michael

AU - Araujo, Sonia

AU - Asiimwe, Alex

AU - Auffray, Charles

AU - Balaur, Irina

AU - Bayer, Katharina

AU - Bernini, Chiara

AU - Bjartell, Anders

AU - Briganti, Alberto

AU - Butler-Ransohoff, John-Edward

AU - Campi, Riccardo

AU - Cavelaars, Marinel

AU - De Meulder, Bertrand

AU - Devecseri, Zsuzsanna

AU - Voss, Marc Dietrich

AU - Dimitropoulos, Konstantinos

AU - Evans-Axelsson, Susan

AU - Franks, Billy

AU - Fullwood, Louise

AU - Horgan, Denis

AU - Smith, Emma Jane

AU - Kiran, Amit

AU - Kivinummi, Kati

AU - Lambrecht, Mark

AU - Lancet, Doron

AU - Lindgren, Peter

AU - MacLennan, Sara

AU - MacLennan, Steven

AU - Nogueira, Maria Manuela

AU - Moen, Fredrik

AU - Moinat, Maxim

AU - Papineni, Kishore

AU - Reich, Christian

AU - Reiche, Kristin

AU - Rogiers, Stijn

AU - Sartini, Claudio

AU - van Bochove, Kees

AU - van Diggelen, Femke

AU - van Hemelrijck, Mieke

AU - Van Poppel, Hein

AU - Zong, Jihong

AU - N'Dow, James

AU - The PIONEER Consortium

N1 - Author Correction: 25 June 2020 The originally published article contained errors in Figure 1 and did not reflect the current organization of the PIONEER consortium. The figure has been corrected in the HTML and PDF versions of the manuscript to reflect the correct organization of PIONEER. Acknowledgements PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

PY - 2020/6/25

Y1 - 2020/6/25

N2 - Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe. Launched by the Innovative Medicines Initiative 2 and part of the Big Data for Better Outcomes Programme (BD4BO), the overarching goal of PIONEER is to provide high-quality evidence on prostate cancer management by unlocking the potential of big data. The project has identified critical evidence gaps in prostate cancer care, via a detailed prioritization exercise including all key stakeholders. By standardizing and integrating existing high-quality and multidisciplinary data sources from patients with prostate cancer across different stages of the disease, the resulting big data will be assembled into a single innovative data platform for research. Based on a unique set of methodologies, PIONEER aims to advance the field of prostate cancer care with a particular focus on improving prostate-cancer-related outcomes, health system efficiency by streamlining patient management, and the quality of health and social care delivered to all men with prostate cancer and their families worldwide.

AB - Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe. Launched by the Innovative Medicines Initiative 2 and part of the Big Data for Better Outcomes Programme (BD4BO), the overarching goal of PIONEER is to provide high-quality evidence on prostate cancer management by unlocking the potential of big data. The project has identified critical evidence gaps in prostate cancer care, via a detailed prioritization exercise including all key stakeholders. By standardizing and integrating existing high-quality and multidisciplinary data sources from patients with prostate cancer across different stages of the disease, the resulting big data will be assembled into a single innovative data platform for research. Based on a unique set of methodologies, PIONEER aims to advance the field of prostate cancer care with a particular focus on improving prostate-cancer-related outcomes, health system efficiency by streamlining patient management, and the quality of health and social care delivered to all men with prostate cancer and their families worldwide.

KW - prostate

KW - prostate cancer

KW - SET

KW - MEN

KW - SURVEILLANCE

KW - RISK

KW - PATIENT-CENTERED OUTCOMES

UR - http://www.scopus.com/inward/record.url?scp=85085488421&partnerID=8YFLogxK

U2 - 10.1038/s41585-020-0324-x

DO - 10.1038/s41585-020-0324-x

M3 - Article

C2 - 32461687

SN - 1759-4820

VL - 17

SP - 351

EP - 362

JO - Nature reviews. Urology

JF - Nature reviews. Urology

ER -

Introducing PIONEER: a project to harness big data in prostate cancer research

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this